United States Pharmacopoeia (USP) Solutions and Reagents

United States Pharmacopoeia (USP) solutions and reagents are crucial for ensuring the safety, quality, and efficacy of pharmaceuticals in the U.S. market. These products comply with the standards set by the USP and are widely used in drug development and quality control. CymitQuimica offers a comprehensive range of USP-compliant solutions and reagents to support pharmaceutical research and manufacturing.

USP Proficiency Testing Program

Products of "United States Pharmacopoeia (USP) Solutions and Reagents"

20
- 50
- 100
- 200

products per page. 6533 products on this category.

Product data	Purity	Price range	Estimated delivery
Torsemide Related Compound A (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide) REF: 45-1672315CAS: 72811-73-5	- - -	1,611.00 €	Fri 11 Oct 24
Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid) REF: 45-1042930CAS: 114176-52-2	- - -	1,371.00 €	Fri 11 Oct 24
Phenoxybenzamine Alcohol (2-[Benzyl(1-phenoxypropan-2-yl)amino]ethan-1-ol) REF: 45-1525999CAS: 101-45-1	- - -	1,583.00 €	Fri 11 Oct 24
Fosinopril Related Compound H (4-phenylbutyl phosphonic acid) REF: 45-1283481CAS: 46348-61-2	- - -	1,371.00 €	Fri 11 Oct 24
Triptorelin Related Compound B REF: 45-1696128CAS: 321709-35-7	- - -	1,276.00 €	Fri 11 Oct 24
Indinavir REF: 45-1339178CAS: 180683-37-8	- - -	408.00 €	Fri 11 Oct 24
Chlorothiophene carboxylic acid (5-chlorothiophene-2-carboxylic acid) REF: 45-1A01180CAS: 24065-33-6	- - -	1,259.00 €	Fri 11 Oct 24
Prostaglandin B1 ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid) REF: 45-1578554CAS: 13345-51-2	- - -	3,680.00 €	Fri 11 Oct 24
Lysophosphatidylcholine REF: 45-1372050CAS: 9008-30-4	- - -	632.00 €	Fri 11 Oct 24
Astragaloside IV ((3β,6α,9β,16β,20R,24S)-16,25-Dihydroxy-3-(β-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside) REF: 45-1044108CAS: 84687-43-4	- - -	391.00 €	Fri 11 Oct 24
Raloxifene Hydrochloride REF: 45-1598201CAS: 82640-04-8	- - -	447.00 €	Fri 11 Oct 24
Lonicera Macranthoides Flower Dry Extract (Mixture, with identified compendial components Dipsacoside B, Macranthoidin A and Macranthoidin B) REF: 45-1369703	- - -	192.00 €	Fri 11 Oct 24
Norgestrel Related Compound L (13-Ethylgon-4-ene-3,17-dione) REF: 45-1472043CAS: 21800-83-9	- - -	1,292.00 €	Fri 11 Oct 24
Cefadroxil Related Compound B ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid) REF: 45-1097126CAS: 22252-43-3	- - -	1,292.00 €	Fri 11 Oct 24
Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate) REF: 45-1010208CAS: 145576-25-6	- - -	1,346.00 €	Fri 11 Oct 24
β Alanine REF: 45-1012495CAS: 107-95-9	- - -	502.00 €	Fri 11 Oct 24
Paclitaxel Impurity Mixture (This mixture contains paclitaxel and paclitaxel benzyl analog) REF: 45-1491365	- - -	1,552.00 €	Fri 11 Oct 24
Metoclopramide Related Compound B (Methyl 4-acetamido-5-chloro-2-methoxybenzoate) REF: 45-1440820CAS: 4093-31-6	- - -	1,371.00 €	Fri 11 Oct 24
Residual Solvent Class 2 - 1,4-Dioxane REF: 45-1601521CAS: 123-91-1	- - -	447.00 €	Fri 11 Oct 24
Carbinoxamine Related Compound A ((4-Chlorophenyl)(pyridin-2-yl)methanone) REF: 45-1096019CAS: 6318-51-0	- - -	1,308.00 €	Fri 11 Oct 24

United States Pharmacopoeia (USP) Solutions and Reagents

Subcategories of "United States Pharmacopoeia (USP) Solutions and Reagents"

USP Proficiency Testing Program

Products of "United States Pharmacopoeia (USP) Solutions and Reagents"

Torsemide Related Compound A (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)

Ref: 45-1672315

Articaine Related Compound B (4-methyl-3-{[2-(propylamino)propanoyl]amino}thiophene-2-carboxylic acid)

Ref: 45-1042930

Phenoxybenzamine Alcohol (2-[Benzyl(1-phenoxypropan-2-yl)amino]ethan-1-ol)

Ref: 45-1525999

Fosinopril Related Compound H (4-phenylbutyl phosphonic acid)

Ref: 45-1283481

Triptorelin Related Compound B

Ref: 45-1696128

Indinavir

Ref: 45-1339178

Chlorothiophene carboxylic acid (5-chlorothiophene-2-carboxylic acid)

Ref: 45-1A01180

Prostaglandin B1 ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid)

Ref: 45-1578554

Lysophosphatidylcholine

Ref: 45-1372050

Astragaloside IV ((3β,6α,9β,16β,20R,24S)-16,25-Dihydroxy-3-(β-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside)

Ref: 45-1044108

Raloxifene Hydrochloride

Ref: 45-1598201

Lonicera Macranthoides Flower Dry Extract (Mixture, with identified compendial components Dipsacoside B, Macranthoidin A and Macranthoidin B)

Ref: 45-1369703

Norgestrel Related Compound L (13-Ethylgon-4-ene-3,17-dione)

Ref: 45-1472043

Cefadroxil Related Compound B ((6R,7R)-7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid)

Ref: 45-1097126

Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)

Ref: 45-1010208

β Alanine

Ref: 45-1012495

Paclitaxel Impurity Mixture (This mixture contains paclitaxel and paclitaxel benzyl analog)

Ref: 45-1491365

Metoclopramide Related Compound B (Methyl 4-acetamido-5-chloro-2-methoxybenzoate)

Ref: 45-1440820

Residual Solvent Class 2 - 1,4-Dioxane

Ref: 45-1601521

Carbinoxamine Related Compound A ((4-Chlorophenyl)(pyridin-2-yl)methanone)

Ref: 45-1096019